PubRank

P W Eggers

Author PubWeight™ 43.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996 9.46
2 Pre-enrollment reimbursement patterns of Medicare beneficiaries enrolled in "at-risk" HMOs. Health Care Financ Rev 1982 4.81
3 Twenty years of Medicare and Medicaid: covered populations, use of benefits, and program expenditures. Health Care Financ Rev 1985 3.78
4 Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int 2006 2.85
5 Trends in Medicare reimbursement for end-stage renal disease: 1974-1979. Health Care Financ Rev 1984 2.44
6 The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financ Rev 1984 2.35
7 The first 3 years of Medicare prospective payment: an overview. Health Care Financ Rev 1988 2.16
8 Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996 1.63
9 Thirty years of Medicare: impact on the covered population. Health Care Financ Rev 1996 1.29
10 End state renal disease among Native Americans, 1983-86. Am J Public Health 1990 1.26
11 Understanding disparities in the use of Medicare services. Yale J Health Policy Law Ethics 2001 1.19
12 Trends in the US end-stage renal disease population: 1973-1983. Am J Kidney Dis 1987 1.18
13 Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. JAMA 1992 1.13
14 Early dosing practices and effectiveness of recombinant human erythropoietin. Kidney Int 1993 1.07
15 Early adoption of cyclosporine and recombinant human erythropoietin: clinical, economic, and policy issues with emergence of high-cost drugs. Am J Kidney Dis 1994 1.03
16 Prospective payment system and quality: early results and research strategy. Health Care Financ Rev 1987 1.01
17 Development of an end-stage renal disease managed care demonstration. Adv Ren Replace Ther 1997 0.95
18 Renal replacement therapy in the United States: data from the United States Renal Data System. Am J Kidney Dis 1995 0.95
19 The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients. Med Care 1994 0.93
20 A review of the first year of Medicare coverage of erythropoietin. Health Care Financ Rev 1994 0.89
21 Trends in use, cost, and outcomes of human recombinant erythropoietin, 1989-98. Health Care Financ Rev 1999 0.85
22 Recombinant erythropoietin and Medicare payment. JAMA 1991 0.75
23 The effect of cyclosporine on the use of hospital resources for kidney transplantation. N Engl J Med 1990 0.75
24 Patterns of utilization among members of a prepaid group practice. Inquiry 1976 0.75
25 Epidemiology working group on morbidity and mortality of end-stage renal disease. Am J Kidney Dis 1993 0.75